Medical and Scientific Publishing: Author, Editor, and Reviewer Perspectives



Very few doctors and scientists receive any sort of systematic training in publishing, editing, and reviewing scholarly articles, despite the central importance of that work for scientific research and for their careers. Medical and Scientific Publishing will help fill the gap and help readers to: Understand processes of scientific and medical publishing Understand the role of an academic in medical publishing Become a better scientific communicator Develop skills to effectively serve as the editor of a medical journal Medical and Scientific Publishing is based on a successful course at the University of Michigan Medical School for third and fourth year medical students. The course teaches students not just how to write scientific and medical articles, but addresses key issues surrounding copyright, ethics, open access and much more. Students will build a strong foundation on how to do peer review and how to be authors and editors which are important skills in building a professional career. Covers a full range of essential information - explanation of publishing licenses, copyright and permissions, how to do peer review, how to write effectively, how journal publishing works, and much more Emphasizes rigor, quality, and scientific integrity in writing, editing, and publishing Focuses on authorship and editorial skills by experienced authors and publishers. © 2018 The Regents of the University of Michigan. Published by Elsevier Inc. All rights reserved.
... Bilimsel yayın sürecinde yazar, editör, dergi, hakem kurulları ve yayınevleri gibi birbirinden ayrı düşünülemez paydaşlar söz konusudur (Markovac, Kleinman & Englesbe, 2017). Her bir paydaşın birbirinden ayrı görev ve sorumlulukları olduğu gibi yayın etiği ile ilgili uymaları gereken farklı kuralları vardır. ...
... The SARS-CoV-2 and COVID-19 pre-print publications are continuing to appear at a staggering pace, which leads to the need for new platforms to keep up with the aggregation and analysis challenges [8]. The much-debated and sometimes doubted future of the peer-reviewed scientific journal remains strong even after this pandemic experience [9,10]. The immediate lesson for us in Mycopathologia is to explore options to present pre-peer-review versions of the manuscript because a lag in publishing is not acceptable in a pandemic or other time! ...
The 2020 COVID-19 pandemic had a profound impact on the publishing landscape. The 'pre-peer-review' publication model is likely to become common as a lag in publishing is not acceptable in a pandemic or other time! Mycopathologia is well placed to adopt such changes with its improved editorial processes, article formats, author engagements, and published articles' access and citation. Mycopathologia had an improved journal impact factor and article downloads in 2018-2019. A limited sampling suggested a slight decrease in the total submissions in 2019 (352 articles) compared to 2018 (371 articles). However, the acceptance rate improved to 30% in 2019 from 19% in 2018. Nearly half of all submissions in 2019 were rejected before peer-review or transferred to other Springer Nature journals. The published articles were contributed from 34 different countries, with authors from China, the USA, and Brazil among the top three contributors. An enhanced editorial oversight allowed peer-reviewers to focus on fewer articles that were well-matched to their expertise, which led to lower rejection rates post-peer-review. The introduction of MycopathologiaGENOME and MycopathologiaIMAGE article types received a good reception with notable downloads and citations.
ResearchGate has not been able to resolve any references for this publication.